Siren, L.L.C. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002005245

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 100 positions · Total reported value $3.61B · Top-10 concentration 49.8% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.7% · 15 new · 36 cut · 22 exited

Active Share (vs S&P 500): 97.6% · vs QQQ: 97.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -13.5% · vs SPY -15.6% · Prev Value $4.93B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.2% · vs SPY -6.4% · Latest Value $4.21B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, Siren, L.L.C. disclosed 100 equity positions with a combined reported value of $3.61B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 49.8% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were SRRK ($532.16M), KYMR ($265.43M), ERAS ($181.93M). By sector, the heaviest allocations are Health Care 90.4%, Technology 4.7%. Versus the prior quarter, allocation shifted toward Health Care (+6.4pp) and away from Communication Services (-0.5pp), Other (-5.7pp).

Versus the prior quarter, Siren, L.L.C. opened 15 new positions, trimmed 36 and fully exited 22, a turnover rate of 55.7% of positions. The portfolio's overlap with the prior quarter was 61% of names.

The largest new positions opened in Q1 2026 were MANE ($95.06M), CYTK ($40.47M), ELVN ($29.25M).

Of the 22 positions fully exited versus the prior quarter, the largest were APLS ($64.77M), ASND ($50.30M), RAPT ($46.57M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • MANE Veradermics, Incorporated · $95.06M
  • CYTK Cytokinetics, Incorporated · $40.47M
  • ELVN Enliven Therapeutics, Inc. · $29.25M
  • DMRA Damora Therapeutics Inc · $23.31M
  • ANNX Annexon, Inc. · $21.93M
  • DFTX DEFINIUM THERAPEUTICS INC · $17.38M
  • AMLX Amylyx Pharmaceuticals, Inc. · $17.10M
  • QURE UNIQURE NV · $16.35M

Fully Exited (vs previous quarter)

  • APLS APELLIS PHARMACEUTICALS INC · prev qtr: $64.77M
  • ASND ASCENDIS PHARMA A/S · prev qtr: $50.30M · history
  • RAPT RAPT THERAPEUTICS INC · prev qtr: $46.57M
  • ZYME ZYMEWORKS INC · prev qtr: $44.24M
  • MLYS MINERALYS THERAPEUTICS INC · prev qtr: $25.40M
  • IHS IHS HOLDING LIMITED · prev qtr: $17.59M
  • UPB UPSTREAM BIO INC COM · prev qtr: $15.98M
  • MNMD MIND MEDICINE MINDMED INC · prev qtr: $10.71M

Insider Transactions (Form 4)

Latest Siren, L.L.C. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Siren, L.L.C. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 116 positions worth $4.93B in total. HoldingsHub carries 8 quarters of its filings (Q3 2024–Q2 2026).

Portfolio Structure

  • 116 positions · $4.93B reported value (Q2 2026)
  • Top 10 holdings = 44.8% of reported value
  • Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 10.7%
  • Average position size: $42.48M

Sector Tilt

  • Health Care 92.0%
  • Information Technology 4.5%
  • Consumer Discretionary 1.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 32 added, 21 reduced, 9 exited
  • 38 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 90.4%
Technology 4.7%
Financials 0.1%
Energy 0.1%
Other 3.1%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 10.83M $532.16M 14.75%
14.75%
Hold
2 3.19M $265.43M 7.36%
7.36%
Reduce
3 11.24M $181.93M 5.04%
5.04%
Add
4 4.43M $139.55M 3.87%
3.87%
Reduce
5 465.00K $138.09M 3.83%
3.83%
Reduce
6 5.66M $118.35M 3.28%
3.28%
Reduce
7 5.80M $115.42M 3.20%
3.20%
Add
8 1.11M $108.04M 3.00%
3.00%
Reduce
9 1.62M $101.29M 2.81%
2.81%
Add
10 1.51M $95.06M 2.63%
2.63%
New
11 1.32M $76.67M 2.12%
2.12%
Add
12 4.76M $70.93M 1.97%
1.97%
Add
13 1.90M $69.14M 1.92%
1.92%
Add
14 44.30M $69.11M 1.92%
1.92%
Add
15 1.71M $65.79M 1.82%
1.82%
Add
16 2.00M $64.97M 1.80%
1.80%
Reduce
17 3.01M $64.95M 1.80%
1.80%
Hold
18 1.33M $64.04M 1.77%
1.77%
Add
19 988.40K $63.20M 1.75%
1.75%
Hold
20 725.51K $63.10M 1.75%
1.75%
Add
21 7.69M $55.37M 1.53%
1.53%
Hold
22 2.00M $48.06M 1.33%
1.33%
Hold
23 1.05M $41.84M 1.16%
1.16%
Reduce
24 818.60K $41.29M 1.15%
1.15%
Hold
25 613.95K $40.47M 1.12%
1.12%
New
26 2.23M $40.41M 1.12%
1.12%
Reduce
27 8.83M $39.47M 1.09%
1.09%
Reduce
28 1.86M $38.80M 1.08%
1.08%
Hold
29 3.00M $37.99M 1.05%
1.05%
Add
30 5.25M $35.77M 0.99%
0.99%
Add
31 257.49K $32.10M 0.89%
0.89%
Add
32 9.97M $30.91M 0.86%
0.86%
Hold
33 746.23K $29.25M 0.81%
0.81%
New
34 1.40M $26.81M 0.74%
0.74%
Hold
35 1.54M $24.18M 0.67%
0.67%
Reduce
36 900.00K $23.31M 0.65%
0.65%
New
37 3.73M $22.22M 0.62%
0.62%
Add
38 3.96M $21.93M 0.61%
0.61%
New
39 1.79M $21.32M 0.59%
0.59%
Reduce
40 641.47K $20.07M 0.56%
0.56%
Reduce
41 65.70K $18.89M 0.52%
0.52%
Add
42 2.35M $18.02M 0.50%
0.50%
Add
43 2.45M $17.76M 0.49%
0.49%
Hold
44 919.49K $17.38M 0.48%
0.48%
New
45 1.23M $17.10M 0.47%
0.47%
New
46 1.19M $16.96M 0.47%
0.47%
Hold
47 8.50M $16.57M 0.46%
0.46%
Add
48 1.00M $16.35M 0.45%
0.45%
New
49 3.46M $16.25M 0.45%
0.45%
New
50 89.08K $15.54M 0.43%
0.43%
Add

FAQ

What did Siren, L.L.C. buy in 2026-Q1?

In its 2026-Q1 13F filing, Siren, L.L.C. reported 100 equity positions worth $3.61B in aggregate; its largest disclosed positions were SRRK ($532.16M), KYMR ($265.43M), ERAS ($181.93M).

How large is Siren, L.L.C.'s portfolio?

Siren, L.L.C. reported $3.61B of long equity holdings across 100 positions as of 2026-Q1. Top-10 holdings account for 49.8% of reported value.

What is Siren, L.L.C.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/siren/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →